59 related articles for article (PubMed ID: 15272278)
1. Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
Chitale DA; Jungbluth AA; Marshall DS; Leitao MM; Hedvat CV; Kolb D; Spagnoli GC; Iversen K; Soslow RA
Mod Pathol; 2005 Jan; 18(1):119-26. PubMed ID: 15272278
[TBL] [Abstract][Full Text] [Related]
2. Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.
Balafoutas D; zur Hausen A; Mayer S; Hirschfeld M; Jaeger M; Denschlag D; Gitsch G; Jungbluth A; Stickeler E
BMC Cancer; 2013 Jun; 13():271. PubMed ID: 23731661
[TBL] [Abstract][Full Text] [Related]
3. MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy.
de Carvalho F; Alves VL; Braga WM; Xavier CV; Colleoni GW
Cancer Immunol Immunother; 2013 Jan; 62(1):191-5. PubMed ID: 23180015
[TBL] [Abstract][Full Text] [Related]
4. Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients.
Inaoka RJ; Jungbluth AA; Gnjatic S; Ritter E; Hanson NC; Frosina D; Tassello J; Etto LY; Bortoluzzo AB; Alves AC; Colleoni GW
Cancer Immunol Immunother; 2012 Dec; 61(12):2207-14. PubMed ID: 22638551
[TBL] [Abstract][Full Text] [Related]
5. MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome.
Tinguely M; Jenni B; Knights A; Lopes B; Korol D; Rousson V; Curioni Fontecedro A; Cogliatti SB; Bittermann AG; Schmid U; Dommann-Scherrer C; Maurer R; Renner C; Probst-Hensch NM; Moch H; Knuth A; Zippelius A
Cancer Sci; 2008 Apr; 99(4):720-5. PubMed ID: 18307538
[TBL] [Abstract][Full Text] [Related]
6. NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches.
Baia GS; Caballero OL; Ho JS; Zhao Q; Cohen T; Binder ZA; Salmasi V; Gallia GL; Quinones-Hinojosa A; Olivi A; Brem H; Burger P; Strausberg RL; Simpson AJ; Eberhart CG; Riggins GJ
Cancer Immunol Res; 2013 Nov; 1(5):296-302. PubMed ID: 24777967
[TBL] [Abstract][Full Text] [Related]
7. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
Wölfl M; Jungbluth AA; Garrido F; Cabrera T; Meyen-Southard S; Spitz R; Ernestus K; Berthold F
Cancer Immunol Immunother; 2005 Apr; 54(4):400-6. PubMed ID: 15449039
[TBL] [Abstract][Full Text] [Related]
8. Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer.
Alves PM; Lévy N; Bouzourene H; Viatte S; Bricard G; Ayyoub M; Vuilleumier H; Givel JC; Halkic N; Speiser DE; Romero P; Lévy F
Cancer Immunol Immunother; 2007 Jun; 56(6):839-47. PubMed ID: 16960690
[TBL] [Abstract][Full Text] [Related]
9. Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets.
Xiao J; Huang F; Li L; Zhang L; Xie L; Liu B
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15003-15011. PubMed ID: 37610673
[TBL] [Abstract][Full Text] [Related]
10. Cancer/testis (CT) antigens: potential targets for immunotherapy.
Caballero OL; Chen YT
Cancer Sci; 2009 Nov; 100(11):2014-21. PubMed ID: 19719775
[TBL] [Abstract][Full Text] [Related]
11. NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma.
Ueda S; Miyahara Y; Nagata Y; Sato E; Shiraishi T; Harada N; Ikeda H; Shiku H; Kageyama S
Oncotarget; 2018 Nov; 9(89):35997-36011. PubMed ID: 30542513
[TBL] [Abstract][Full Text] [Related]
12. MAGE-A10 Protein Expression in Advanced High Grade Serous Ovarian Cancer Is Associated with Resistance to First-Line Platinum-Based Chemotherapy.
Lisica Šikić N; Petrić Miše B; Tomić S; Spagnol G; Matak L; Juretić A; Spagnoli G
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835391
[TBL] [Abstract][Full Text] [Related]
13. NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
Theurillat JP; Zürrer-Härdi U; Varga Z; Storz M; Probst-Hensch NM; Seifert B; Fehr MK; Fink D; Ferrone S; Pestalozzi B; Jungbluth AA; Chen YT; Jäger D; Knuth A; Moch H
Cancer Immunol Immunother; 2007 Nov; 56(11):1723-31. PubMed ID: 17410359
[TBL] [Abstract][Full Text] [Related]
14. Proteogenomic Characterization of Endometrial Carcinoma.
Dou Y; Kawaler EA; Cui Zhou D; Gritsenko MA; Huang C; Blumenberg L; Karpova A; Petyuk VA; Savage SR; Satpathy S; Liu W; Wu Y; Tsai CF; Wen B; Li Z; Cao S; Moon J; Shi Z; Cornwell M; Wyczalkowski MA; Chu RK; Vasaikar S; Zhou H; Gao Q; Moore RJ; Li K; Sethuraman S; Monroe ME; Zhao R; Heiman D; Krug K; Clauser K; Kothadia R; Maruvka Y; Pico AR; Oliphant AE; Hoskins EL; Pugh SL; Beecroft SJI; Adams DW; Jarman JC; Kong A; Chang HY; Reva B; Liao Y; Rykunov D; Colaprico A; Chen XS; Czekański A; Jędryka M; Matkowski R; Wiznerowicz M; Hiltke T; Boja E; Kinsinger CR; Mesri M; Robles AI; Rodriguez H; Mutch D; Fuh K; Ellis MJ; DeLair D; Thiagarajan M; Mani DR; Getz G; Noble M; Nesvizhskii AI; Wang P; Anderson ML; Levine DA; Smith RD; Payne SH; Ruggles KV; Rodland KD; Ding L; Zhang B; Liu T; Fenyö D;
Cell; 2020 Feb; 180(4):729-748.e26. PubMed ID: 32059776
[TBL] [Abstract][Full Text] [Related]
15. Identification, expression, and nuclear location of murine Mage-b2 protein, a tumor-associated antigen.
Lee JH; Sung BW; Youn HJ; Park JH
Mol Cells; 2000 Dec; 10(6):647-53. PubMed ID: 11211869
[TBL] [Abstract][Full Text] [Related]
16. High Expression of WT1 and Low Expression of p53 in Archived Blocks of Children with Wilms Tumor in South Western Uganda.
Ssenkumba B; Atwiine B; Mitala Y; Adongo J; Olowo S; Nabulya R; Diaz Anaya A; Atwine R
Cancer Manag Res; 2024; 16():127-136. PubMed ID: 38476972
[TBL] [Abstract][Full Text] [Related]
17. Clear cell carcinomas of the mullerian system: does the pathogenesis vary depending on their nuclear grade and their association with endometriosis? An immunohistochemical analysis.
Alduaij A; Hansen K; Karim TA; Zhang C; Lomme MM; Sung CJ; Lawrence WD; Quddus MR
Patholog Res Int; 2012; 2012():674748. PubMed ID: 23213623
[TBL] [Abstract][Full Text] [Related]
18. High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx.
Figueiredo DL; Mamede RC; Spagnoli GC; Silva WA; Zago M; Neder L; Jungbluth AA; Saggioro FP
Head Neck; 2011 May; 33(5):702-7. PubMed ID: 20886663
[TBL] [Abstract][Full Text] [Related]
19. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
20. MAGE-A3 with cell-penetrating domain as an efficient therapeutic cancer vaccine.
Batchu RB; Gruzdyn O; Potti RB; Weaver DW; Gruber SA
JAMA Surg; 2014 May; 149(5):451-7. PubMed ID: 24671426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
